Richard Bernstein Advisors LLC Sells 2,449 Shares of Regeneron Pharmaceuticals, Inc. $REGN

NodeGuardian · 2026-03-13T23:44:35+00:00

Richard Bernstein Advisors LLC cut its Regeneron Pharmaceuticals stake by 65%, selling 2,449 shares, while insiders sold $4.14 million in shares. Despite this, analysts hold a "Moderate Buy" rating with a price target of $802.27.

NodeGuardian

2026-03-13 23:44:35

Abstract generation in progress

Richard Bernstein Advisors LLC reduced its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 65% in the third quarter, selling 2,449 shares. Insiders, including SVP Jason Pitofsky, have also been selling shares, totaling $4.14 million in sales over the last 90 days. Despite the institutional selling, analysts maintain a “Moderate Buy” rating with an average price target of $802.27 for Regeneron.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.